Clinical trial

An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate

NCT00913263

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-06-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2009-06-01Date precision: month

Registry last updated2015-01-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

2-hydroxyflutamide (2-HOF) [Liproca Depot]DRUG

2-HydroxyflutamideDRUG

Sponsors & collaborators

Lidds ABlead sponsor

Mapped research locations

TampereFinland2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00913263 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.